U.S. flag

An official website of the United States government

NM_198904.4(GABRG2):c.1113_1115del (p.Lys374del) AND multiple conditions

Germline classification:
Uncertain significance (1 submission)
Last evaluated:
Nov 11, 2024
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV001223368.7

Allele description [Variation Report for NM_198904.4(GABRG2):c.1113_1115del (p.Lys374del)]

NM_198904.4(GABRG2):c.1113_1115del (p.Lys374del)

Gene:
GABRG2:gamma-aminobutyric acid type A receptor subunit gamma2 [Gene - OMIM - HGNC]
Variant type:
Deletion
Cytogenetic location:
5q34
Genomic location:
Preferred name:
NM_198904.4(GABRG2):c.1113_1115del (p.Lys374del)
HGVS:
  • NC_000005.10:g.162149298_162149300del
  • NG_009290.1:g.86657_86659del
  • NM_000816.3:c.1113_1115del
  • NM_001375339.1:c.1104_1106del
  • NM_001375340.1:c.923-2432_923-2430del
  • NM_001375341.1:c.1110_1112del
  • NM_001375342.1:c.1110_1112del
  • NM_001375343.1:c.1233_1235del
  • NM_001375344.1:c.1152_1154del
  • NM_001375345.1:c.1047_1049del
  • NM_001375346.1:c.1047_1049del
  • NM_001375347.1:c.1026_1028del
  • NM_001375348.1:c.693_695del
  • NM_001375349.1:c.828_830del
  • NM_001375350.1:c.693_695del
  • NM_198903.2:c.1233_1235del
  • NM_198904.4:c.1113_1115delMANE SELECT
  • NP_000807.2:p.Lys374del
  • NP_001362268.1:p.Lys371del
  • NP_001362270.1:p.Lys373del
  • NP_001362271.1:p.Lys373del
  • NP_001362272.1:p.Lys414del
  • NP_001362273.1:p.Lys387del
  • NP_001362274.1:p.Lys352del
  • NP_001362275.1:p.Lys352del
  • NP_001362276.1:p.Lys345del
  • NP_001362277.1:p.Lys234del
  • NP_001362278.1:p.Lys279del
  • NP_001362279.1:p.Lys234del
  • NP_944493.2:p.Lys414del
  • NP_944494.1:p.Lys374del
  • NC_000005.9:g.161576302_161576304del
  • NC_000005.9:g.161576304_161576306del
  • NM_000816.3:c.1113_1115delAAA
  • p.K374del
Protein change:
K234del
Links:
dbSNP: rs727503941
NCBI 1000 Genomes Browser:
rs727503941
Molecular consequence:
  • NM_000816.3:c.1113_1115del - inframe_deletion - [Sequence Ontology: SO:0001822]
  • NM_001375339.1:c.1104_1106del - inframe_deletion - [Sequence Ontology: SO:0001822]
  • NM_001375341.1:c.1110_1112del - inframe_deletion - [Sequence Ontology: SO:0001822]
  • NM_001375342.1:c.1110_1112del - inframe_deletion - [Sequence Ontology: SO:0001822]
  • NM_001375343.1:c.1233_1235del - inframe_deletion - [Sequence Ontology: SO:0001822]
  • NM_001375344.1:c.1152_1154del - inframe_deletion - [Sequence Ontology: SO:0001822]
  • NM_001375345.1:c.1047_1049del - inframe_deletion - [Sequence Ontology: SO:0001822]
  • NM_001375346.1:c.1047_1049del - inframe_deletion - [Sequence Ontology: SO:0001822]
  • NM_001375347.1:c.1026_1028del - inframe_deletion - [Sequence Ontology: SO:0001822]
  • NM_001375348.1:c.693_695del - inframe_deletion - [Sequence Ontology: SO:0001822]
  • NM_001375349.1:c.828_830del - inframe_deletion - [Sequence Ontology: SO:0001822]
  • NM_001375350.1:c.693_695del - inframe_deletion - [Sequence Ontology: SO:0001822]
  • NM_198903.2:c.1233_1235del - inframe_deletion - [Sequence Ontology: SO:0001822]
  • NM_198904.4:c.1113_1115del - inframe_deletion - [Sequence Ontology: SO:0001822]
  • NM_001375340.1:c.923-2432_923-2430del - intron variant - [Sequence Ontology: SO:0001627]

Condition(s)

Name:
EPILEPSY, CHILDHOOD ABSENCE, SUSCEPTIBILITY TO, 2 (ECA2)
Identifiers:
MedGen: C1843244; Orphanet: 64280
Name:
Febrile seizures, familial, 8 (FEB8)
Synonyms:
CONVULSIONS, FAMILIAL FEBRILE, 8
Identifiers:
MONDO: MONDO:0011891; MedGen: C1969810; Orphanet: 36387; OMIM: 607681

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV001395513Labcorp Genetics (formerly Invitae), Labcorp
criteria provided, single submitter

(Invitae Variant Classification Sherloc (09022015))
Uncertain significance
(Nov 11, 2024)
germlineclinical testing

PubMed (2)
[See all records that cite these PMIDs]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Genetic testing in a cohort of patients with potential epilepsy with myoclonic-atonic seizures.

Angione K, Eschbach K, Smith G, Joshi C, Demarest S.

Epilepsy Res. 2019 Feb;150:70-77. doi: 10.1016/j.eplepsyres.2019.01.008. Epub 2019 Jan 14.

PubMed [citation]
PMID:
30660939

Sherloc: a comprehensive refinement of the ACMG-AMP variant classification criteria.

Nykamp K, Anderson M, Powers M, Garcia J, Herrera B, Ho YY, Kobayashi Y, Patil N, Thusberg J, Westbrook M; Invitae Clinical Genomics Group, Topper S.

Genet Med. 2017 Oct;19(10):1105-1117. doi: 10.1038/gim.2017.37. Epub 2017 May 11. Erratum in: Genet Med. 2020 Jan;22(1):240. doi: 10.1038/s41436-019-0624-9..

PubMed [citation]
PMID:
28492532
PMCID:
PMC5632818

Details of each submission

From Labcorp Genetics (formerly Invitae), Labcorp, SCV001395513.6

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (2)

Description

This variant, c.1113_1115del, results in the deletion of 1 amino acid(s) of the GABRG2 protein (p.Lys374del), but otherwise preserves the integrity of the reading frame. This variant is present in population databases (rs749611954, gnomAD 0.01%). This variant has been observed in individual(s) with epilepsy (PMID: 30660939). ClinVar contains an entry for this variant (Variation ID: 167117). Experimental studies and prediction algorithms are not available or were not evaluated, and the functional significance of this variant is currently unknown. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Apr 13, 2025